• Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys924fs*973 (c.2773delG); Zygosity=Unspecified (PubMed=9230208).
  

PubMed=2878433; DOI=10.1098/rspb.1986.0070
Huschtscha L.I., Thompson K.V.A., Holliday R.
The susceptibility of Werner's syndrome and other human skin fibroblasts to SV40-induced transformation and immortalization.
Proc. R. Soc. Lond. B. Biol. Sci. 229:1-12(1986)

PubMed=2762303; DOI=10.1073/pnas.86.15.5893; PMCID=PMC297737
Fukuchi K.-i., Martin G.M., Monnat R.J. Jr.
Mutator phenotype of Werner syndrome is characterized by extensive deletions.
Proc. Natl. Acad. Sci. U.S.A. 86:5893-5897(1989)

PubMed=9230208
Bennett S.E., Umar A., Oshima J., Monnat R.J. Jr., Kunkel T.A.
Mismatch repair in extracts of Werner syndrome cell lines.
Cancer Res. 57:2956-2960(1997)

CLPUB00712
Henson J.D.
The role of alternative lengthening of telomeres in human cancer.
Thesis PhD (2006); University of Sydney; Sydney; Australia

PubMed=19935656; DOI=10.1038/nbt.1587
Henson J.D., Cao Y., Huschtscha L.I., Chang A.C.-M., Au A.Y.M., Pickett H.A., Reddel R.R.
DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Nat. Biotechnol. 27:1181-1185(2009)

PubMed=22989712; DOI=10.1093/nar/gks862; PMCID=PMC3510502
Mendez-Bermudez A., Hidalgo-Bravo A., Cotton V.E., Gravani A., Jeyapalan J.N., Royle N.J.
The roles of WRN and BLM RecQ helicases in the alternative lengthening of telomeres.
Nucleic Acids Res. 40:10809-10820(2012)